Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.

A case of abiraterone acetate withdrawal syndrome after initiation of upfront abiraterone therapy for high-risk prostate cancer.

Masaru Tani,Yujiro Hayashi,Airi Miki,Teppei Wakita,Yuki Horibe,Yoichi Kakuta,Koichi Tsutahara,Tetsuya Takao

IJU case reports（2023）

Cited 0|Views12
No score
Abstract
Abiraterone acetate withdrawal syndrome was observed when hormone-sensitive prostate cancer with upfront abiraterone therapy progressed to castration-resistant prostate cancer.
More
Translated text
Key words
abiraterone acetate withdrawal syndrome,upfront abiraterone therapy,prostate cancer
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined